A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics ...
A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics ...
The findings suggest that dampening eosinophilic and T2 inflammatory responses result in increases in several alternative inflammatory pathways that contribute to residual exacerbations in children ...
Please provide your email address to receive an email when new articles are posted on . New analyses of the phase 2b PATHWAY study demonstrate that treatment with tezepelumab reduced asthma ...
Please provide your email address to receive an email when new articles are posted on . “At present, we lack noninvasive tests to identify asthma subtypes or endotypes based on these cell types in ...
Credit: Amgen AstraZeneca Tezspire is a first-in-class human monoclonal antibody that works by blocking thymic stromal lymphopoietin. The Food and Drug Administration (FDA) has approved Tezspire™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback